PReS-FINAL-2274: Antiadalimumab antibodies in pediatric rheumatology patients. A pilot experience

por Murias Loza, S, Alcobendas Rueda, RM, Remesal Camba, A, Pascual Salcedo, D, Peralta, J, Merino Muñoz, R
Publicado 2013